Evidence map›Paper›PMID 35539257›Full record

ArticleRSC advances2018

Yunquan Zheng, Qisheng Pan, Liuda Mo, Wenyi Zhang, Yunjian Duan, Chengqun Chen, Haijun Chen, Yanghao Guo, Xianai Shi, Jianmin Yang

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yunquan ZhengCollege of Chemistry, Fuzhou University 2 Xueyuan Road Fuzhou 350116 Fujian 350108 China yunquanzheng@fzu.edu.cn chenhaij@gmail.com +86-591-22866237 +86-591-22866234.ORCID https://orcid.org/0000-0001-5571-2898
Qisheng PanCollege of Chemistry, Fuzhou University 2 Xueyuan Road Fuzhou 350116 Fujian 350108 China yunquanzheng@fzu.edu.cn chenhaij@gmail.com +86-591-22866237 +86-591-22866234.
Liuda MoCollege of Chemistry, Fuzhou University 2 Xueyuan Road Fuzhou 350116 Fujian 350108 China yunquanzheng@fzu.edu.cn chenhaij@gmail.com +86-591-22866237 +86-591-22866234.
Wenyi ZhangCollege of Chemistry, Fuzhou University 2 Xueyuan Road Fuzhou 350116 Fujian 350108 China yunquanzheng@fzu.edu.cn chenhaij@gmail.com +86-591-22866237 +86-591-22866234.
Yunjian DuanCollege of Chemistry, Fuzhou University 2 Xueyuan Road Fuzhou 350116 Fujian 350108 China yunquanzheng@fzu.edu.cn chenhaij@gmail.com +86-591-22866237 +86-591-22866234.
Chengqun ChenDepartment of Chemical Engineering, Fuzhou University, Zhicheng College 523 Gongye Road Fuzhou 350002 China.
Haijun ChenCollege of Chemistry, Fuzhou University 2 Xueyuan Road Fuzhou 350116 Fujian 350108 China yunquanzheng@fzu.edu.cn chenhaij@gmail.com +86-591-22866237 +86-591-22866234.ORCID https://orcid.org/0000-0001-7945-2461
Yanghao GuoFujian Key Laboratory of Medical Instrument and Pharmaceutical Technology, Fuzhou University 2 Xueyuan Road Fuzhou 350116 China.
Xianai ShiFujian Key Laboratory of Medical Instrument and Pharmaceutical Technology, Fuzhou University 2 Xueyuan Road Fuzhou 350116 China.
Jianmin YangFujian Key Laboratory of Medical Instrument and Pharmaceutical Technology, Fuzhou University 2 Xueyuan Road Fuzhou 350116 China.
Fuzhou University · CNFujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is an extremely complex disease, characterized by several pathological features including oxidative stress and amyloid-β (Aβ) aggregation. Blockage of Aβ-induced injury has emerged as a potential therapeutic approach for AD. Our previous efforts resulted in the discovery of

Identifiers

PMID35539257
PMCPMC9080402
OpenAlexW2800120680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.